Jynarque 45MG-15MG
Ended Awarded
- Contract number
- 36C24523N0492
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,225
Award facts
- Contract value 100% obligated
- $12,224.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order for Jynarque (tolvaptan) 45mg-15mg to Otsuka America Pharmaceutical Inc. on April 6, 2023, with a ceiling value of $12,224.60 and an ultimate completion date of April 12, 2023. The contract is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) as a firm fixed-price delivery order with no set-aside designation. Performance will take place in Pittsburgh, Pennsylvania. Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, specializes in developing and distributing specialty pharmaceuticals to the VA, with Jynarque as its primary product for treating autosomal dominant polycystic kidney disease and hyponatremia.
This delivery order is issued under a larger Blanket Purchase Agreement (BPA) between Otsuka America and the VA's National Acquisition Center valued at $83.3 million, which enables streamlined procurement of Jynarque across multiple VA Integrated Service Networks through March 26, 2026. The company also maintains a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products. These indefinite delivery vehicles support the VA's mission to provide specialized pharmaceutical treatments to veterans nationwide, with delivery orders issued to multiple regions across the country on a consistent firm fixed-price basis.
Quick answers
Who was awarded contract 36C24523N0492?
36C24523N0492 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 6, 2023.
How much is contract 36C24523N0492 worth?
The government has obligated $12,225 on 36C24523N0492.
Is contract 36C24523N0492 an order under another contract?
Yes. 36C24523N0492 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24523N0492 competed?
The extent of competition for 36C24523N0492 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award